Thermo Fisher (TMO) Gets a Buy Rating from Credit Suisse

By Carrie Williams

Credit Suisse analyst Lorenzo Biasio maintained a Buy rating on Thermo Fisher (TMOResearch Report) yesterday and set a price target of $310. The company’s shares closed yesterday at $277.68.

According to TipRanks.com, Biasio is a 3-star analyst with an average return of 3.2% and a 58.2% success rate. Biasio covers the Healthcare sector, focusing on stocks such as Clovis Oncology, Merck & Company, and Mylan Inc.

Currently, the analyst consensus on Thermo Fisher is a Strong Buy with an average price target of $316, representing a 13.8% upside. In a report issued on July 25, Needham also maintained a Buy rating on the stock with a $321 price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $305.45 and a one-year low of $208.34. Currently, Thermo Fisher has an average volume of 1.44M.

Based on the recent corporate insider activity of 72 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.